Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
6.38
+0.77 (13.73%)
At close: Aug 13, 2025, 4:00 PM
6.50
+0.12 (1.88%)
After-hours: Aug 13, 2025, 5:06 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $19.91 million as of August 13, 2025. Its market cap has decreased by -64.78% in one year.
Market Cap
19.91M
Enterprise Value
-14.49M
1-Year Change
-64.78%
Ranking
Category
Stock Price
$6.38
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $19.91M, a decrease of -97.92%. That is a compound annual growth rate of -50.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 17.50M | -50.03% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 588.91B |
| Johnson & Johnson | 418.67B |
| AbbVie | 355.08B |
| UnitedHealth Group | 244.25B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.28B |
| Novo Nordisk | 223.00B |